logo

[breadcrumb_custom]

Astrazeneca plc ADR (AZN) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Astrazeneca plc ADR’s current trading price is -12.49% away from its 52-week high, while its distance from the 52-week low is 10.79%. The stock’s price range for this time frame has been between $60.47 and $76.56. The trading volume of the company’s shares in the Healthcare reached around 2.0 million for the day, which was evidently lower than the average daily volume of 6.23 million over the last three months.

Astrazeneca plc ADR’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $76.56 on 04/25/23, and the lowest price during that time was $60.47, recorded on 02/12/24.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

How Financial Performance Impacts Market Capitalization

Astrazeneca plc ADR (AZN) has experienced a quarterly decline of -2.05% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 207.71B and boasts a workforce of 89900 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 65.69, with a change in price of +3.39. Similarly, Astrazeneca plc ADR recorded 5,894,292 in trading volume during the last 100 days, posting a change of +5.33%.

How AZN’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for AZN stands at 0.73. Similarly, the long-term debt-to-equity ratio is also 0.59.

AZN Stock Stochastic Average

Astrazeneca plc ADR’s raw stochastic average for the past 50 days is currently at 82.61%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 62.17%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 66.34% and 74.07%, respectively.

AZN Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Year to date metric has recorded a loss of -0.53%.However, over the last six months, we can see a weaker performance of 0.40%. Over the last 30 days, the price of AZN has fallen by 3.40%. And in the last five days, it has surged by 1.00%.

On Key

Related Posts